Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ocean Optics Users Dive Deep Into Scientific Applications, Driving Record Engagement With Bioz Tools
-
Beijing International Book Fair (BIBF) welcomes record international exhibitors
-
Why You Need a Myrtle Beach Personal Injury Attorney After an Auto Accident
-
Debtor distribution data (CK92) - Totalkredit A/S
-
Debtor distribution data (CK92) - Nykredit Realkredit A/S
-
FirstFarms A/S allocates warrants
-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
Bitget Onboards on India's I4C’s Sahyog Portal to Support Local Law Enforcement
-
Bitget Onboards on India's I4C’s Sahyog Portal to Support Local Law Enforcement
-
Form 8.5 (EPT/RI) - Ricardo PLC
-
Form 8.5 (EPT/RI) - De La Rue plc
-
Mainspring Recovery Opens New Residential Treatment Facility in Lynchburg Bringing Expanded Addiction Recovery Services to Central Virginia
-
IDEX Biometrics ASA: Issue of shares – 23 June 2025
-
Ophævelse af suspension i afdeling under Investeringsforeningen Carnegie Wealth Management
-
Form 8.3 - Dowlais Group plc
-
Antier Shatters DeFi Boundaries: Debuts Enterprise-Level Stablecoin Remittance Solution
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Brighter Signals Emerges from Stealth
-
Antier Brings First-Ever 'Stablecoin Remittance-as-a-Service (RaaS)' Into Blockchain Neo-Banking Apps
-
TRESU Investment Holding A/S – Settlement of interest payment by issuance of interest bonds
-
Monumental Energy Announces Completion of Workover and Resumption of Commercial Production at the Copper Moki-2 Oil and Gas Well in New Zealand
-
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
-
Share buyback programme – week 25
-
Børsmeddelelse: Børsprospekt samt meddelelse om formue og antal investorer i andelsklasserne Horizon3 Innovation Akk., kl n og Hammers Fonde - Forsvar, kl n under Investeringsforeningen PortfolioMan
-
RETRANSMISSION: Inspiration Energy Commences Atomic Mineral Resonance Tomography (AMRT) Survey Over High Priority Drill Targets in Saskatchewan
-
Suspension i forbindelse med fusion
-
Admiral Vending Launches AI Powered Quote Tool to Simplify Office Coffee Machine Leasing in the UK
-
Banking on Inclusion: CI&T and Project Nemo Redefine Financial Access
-
INBRAIN Neuroelectronics Named 2025 World Economic Forum Technology Pioneer
-
3Degrees Strengthens European Biomethane Solutions with ISCC EU Certification
-
OLX Group Reports Strong FY 2025 Results With 18% Revenue Growth and 61% Profit Uplift Year-on-Year
-
B2B Stablecoin Payments Surge 30x to $3 Billion Monthly Volume in 2025
-
Tronsmart's Fiitune X30: Next-Generation Home Speaker with Spatial Audio in High Fidelity
-
Bentley Systems Wins Multiple 2025 Sustainability Delivery Awards
-
Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine
-
Meddelelse om ændring i porteføljeforvaltningshonorar – I&T Globale Aktier ESG Select
-
Offentliggørelse af prospekt, Investeringsforeningen SEBinvest
-
EveLab Insight Debuts Dynamic Wrinkle Detection Technology at VivaTech 2025, Shaping the Future of AI-Powered Skin Wellness
-
Share repurchase programme: Transactions of week 25 2025
-
WySE Products Launches Total Pet Kitchen, The First-of-Its-Kind Multicooker for Fresh Pet Food Preparation at Home
-
HABA celebrates 40 years of camping comfort: from a workplace to global wholesaler
-
LEADING EDGE MATERIALS' INVESTOR UPDATE AND SIGNIFICANT ACTIVITIES
-
141,959 Orion Corporation A shares converted into B shares
-
LEADING EDGE MATERIALS' INVESTOR UPDATE AND SIGNIFICANT ACTIVITIES
-
Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML
-
Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO
-
Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO
-
THEON secures c.€50 million new orders, directing revenue guidance to the upper range (€430 million)
-
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease

